Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response (2021)

First Author: Zhang P

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-20-0177

Publication URI: http://dx.doi.org/10.1158/0008-5472.can-20-0177

Type: Journal Article/Review

Parent Publication: Cancer Research

Issue: 7